Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Comi

Showing results (521-530 of 586) with videos related to

Pageof 59
Sort By:
Clinical Genetics|September 13, 2008
Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlationA Biffi, M Cesani, F Fumagalli, et al.
Molecular Neurobiology|June 28, 2021
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis PatientsG Sferruzza, F Clarelli, E Mascia, et al.
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Cell Death and Differentiation|December 17, 2013
Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesiclesP Joshi, E Turola, A Ruiz, et al.
Gene Therapy|February 2, 2008
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosisE Butti, A Bergami, A Recchia, et al.
Neurology|March 2, 2012
Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosisS Mesaros, M A Rocca, K Kacar, et al.
Neuroimage|October 1, 1996
Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET studyE Paulesu, D Perani, F Fazio, et al.
Brain : a Journal of Neurology|August 22, 2006
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 yearsM Rovaris, E Judica, A Gallo, et al.
Neurology|June 17, 1999
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patientsF L Sciacca, C Ferri, K Vandenbroeck, et al.
Journal of Neurology|February 14, 2018
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patientsF Esposito, L Ferrè, F Clarelli, et al.
Pageof 59

Showing results (521-530 of 586) with videos related to

Sort By:
Pageof 59
Clinical Genetics|September 13, 2008
Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlationA Biffi, M Cesani, F Fumagalli, et al.
Molecular Neurobiology|June 28, 2021
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis PatientsG Sferruzza, F Clarelli, E Mascia, et al.
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Cell Death and Differentiation|December 17, 2013
Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesiclesP Joshi, E Turola, A Ruiz, et al.
Gene Therapy|February 2, 2008
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosisE Butti, A Bergami, A Recchia, et al.
Neurology|March 2, 2012
Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosisS Mesaros, M A Rocca, K Kacar, et al.
Neuroimage|October 1, 1996
Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET studyE Paulesu, D Perani, F Fazio, et al.
Brain : a Journal of Neurology|August 22, 2006
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 yearsM Rovaris, E Judica, A Gallo, et al.
Neurology|June 17, 1999
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patientsF L Sciacca, C Ferri, K Vandenbroeck, et al.
Journal of Neurology|February 14, 2018
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patientsF Esposito, L Ferrè, F Clarelli, et al.
Pageof 59